1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Active Pharmaceutical Ingredient Industry Insights

4.1. Industry Value Chain Analysis

4.1.1.   Vendor Matrix

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company market share analysis,2018

4.6. Porter’s Five forces analysis

4.6.1.   Bargaining Power of Suppliers

4.6.2.   Bargaining Power of Buyers

4.6.3.   Threat of New Entrants

4.6.4.   Threat of Substitutes

4.6.5.   Intensity of Rivalry

4.7. PESTEL Analysis

4.8. Strategic Outlook

5.    Global Active Pharmaceutical Ingredient Market Overview

5.1. Market Size & Forecast 2015-2025

5.1.1.   By Value (USD)

5.2. Market Share & Forecast

5.2.1.   By Manufacturer Type

5.2.1.1.       Captive (In-House) Manufacturer

5.2.1.2.       Merchant (Contract) Manufacturer

5.2.2.   By Active Pharmaceutical Ingredient Type

5.2.2.1.       Synthetic Chemical API

5.2.2.2.       Biotech/Biological API

5.2.2.3.       Plant Extracts API

5.2.2.4.       High-potency API

5.2.2.5.       Classical Fermentation API

5.2.3.   By Drug Type

5.2.3.1.       Branded or Innovative Drug

5.2.3.2.       Generic Prescription Drug

5.2.3.3.       OTC (over the counter) Drug

5.2.3.4.       Other Drug

5.2.4.   By Therapeutic Area

5.2.4.1.       Anti-Infective Drug

5.2.4.2.       Metabolic Disorders Drug

5.2.4.3.       Cardiovascular Drug

5.2.4.4.       Oncology Drug

5.2.4.5.       Central Nervous System Drug

5.2.4.6.       Respiratory Drug

5.2.4.7.       Other Therapeutic Drug

5.2.5.   By Region

5.2.5.1.       North America

5.2.5.2.       Europe

5.2.5.3.       Asia Pacific

5.2.5.4.       Latin America

5.2.5.5.       Middle East & Africa

6.    North America Active Pharmaceutical Ingredient Market

6.1. Key Regional Trends

6.2. Market estimates & forecast

6.2.1.   By Manufacturer Type

6.2.2.   By Active Pharmaceutical Ingredient Type

6.2.3.   By Drug Type

6.2.4.   By Therapeutic Area

6.2.5.   By Country

6.2.5.1.       U.S

6.2.5.2.       Canada

7.    Europe Active Pharmaceutical Ingredient Market

7.1. Key Regional Trends

7.2. Market estimates & forecast

7.2.1.   By Manufacturer Type

7.2.2.   By Active Pharmaceutical Ingredient Type

7.2.3.   By Drug Type

7.2.4.   By Therapeutic Area

7.2.5.   By Country

7.2.5.1.       Germany

7.2.5.2.       U.K

7.2.5.3.       France

7.2.5.4.       Italy

7.2.5.5.       Rest of Europe

8.    Asia Pacific Active Pharmaceutical Ingredient Market

8.1. Key Regional Trends

8.2. Market estimates & forecast

8.2.1.   By Manufacturer Type

8.2.2.   By Active Pharmaceutical Ingredient Type

8.2.3.   By Drug Type

8.2.4.   By Therapeutic Area

8.2.5.   By Country

8.2.5.1.       China

8.2.5.2.       India

8.2.5.3.       Japan

8.2.5.4.       Rest of APAC

9.    Latin America Active Pharmaceutical Ingredient Market

9.1. Key Regional Trends

9.2. Market estimates & forecast

9.2.1.   By Manufacturer Type

9.2.2.   By Active Pharmaceutical Ingredient Type

9.2.3.   By Drug Type

9.2.4.   By Therapeutic Area

9.2.5.   By Country

9.2.5.1.       Brazil

9.2.5.2.       Argentina

9.2.5.3.       Rest of Latin America

10. Middle East & Africa Active Pharmaceutical Ingredient Market

10.1.             Key Regional Trends

10.2.             Market estimates & forecast

10.2.1. By Manufacturer Type

10.2.2. By Active Pharmaceutical Ingredient Type

10.2.3. By Drug Type

10.2.4. By Therapeutic Area

10.2.5. By Country

10.2.5.1.    Saudi Arabia

10.2.5.2.    UAE

10.2.5.3.    South Africa

10.2.5.4.    Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

11.1.             Teva Pharmaceutical Industries Ltd.

11.2.             Boehringer Ingelheim GmbH

11.3.             Sun Pharmaceutical Industries Ltd.

11.4.             Pfizer Inc.

11.5.             Aurobindo Pharma

11.6.             Abbott Laboratories

11.7.             Merck & Co., Inc.

11.8.             Novartis AG

11.9.             Hoffmann-La Roche Ltdss

11.10.          Bayer AG

11.11.          Other Prominent Players

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies